Search

Your search keyword '"Lindner, Lars H."' showing total 490 results
Start Over Author "Lindner, Lars H."
490 results on '"Lindner, Lars H."'

3. Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma – A retrospective multicenter study of the Bavarian university hospitals

Author

Burkhard-Meier, Anton, Grube, Matthias, Jurinovic, Vindi, Agaimy, Abbas, Albertsmeier, Markus, Berclaz, Luc M., Di Gioia, Dorit, Dürr, Hans Roland, von Eisenhart-Rothe, Rüdiger, Eze, Chukwuka, Fechner, Katja, Fey, Emma, Güler, Sinan E., Hecker, Judith S., Hendricks, Anne, Keil, Felix, Klein, Alexander, Knebel, Carolin, Kovács, Julia R., Kunz, Wolfgang G., Lenze, Ulrich, Lörsch, Alisa M., Lutz, Mathias, Meidenbauer, Norbert, Mogler, Carolin, Schmidt-Hegemann, Nina-Sophie, Semrau, Sabine, Sienel, Wulf, Trepel, Martin, Waldschmidt, Johannes, Wiegering, Armin, and Lindner, Lars H.

Published
2024
Full Text
View/download PDF

6. A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers

Author

Ademaj, Adela, Veltsista, Paraskevi D., Marder, Dietmar, Hälg, Roger A., Puric, Emsad, Brunner, Thomas B., Crezee, Hans, Gabrys, Dorota, Franckena, Martine, Gani, Cihan, Horsman, Michael R., Krempien, Robert, Lindner, Lars H., Maluta, Sergio, Notter, Markus, Petzold, Griseldis, Abdel-Rahman, Sultan, Richetti, Antonella, Thomsen, Andreas R., Tsoutsou, Pelagia, Fietkau, Rainer, Ott, Oliver J., Ghadjar, Pirus, and Riesterer, Oliver

Published
2023
Full Text
View/download PDF

7. Ten recommendations for sarcoma surgery: consensus of the surgical societies based on the German S3 guideline “Adult Soft Tissue Sarcomas”

Author

Jakob, Jens, Andreou, Dimosthenis, Bedke, Jens, Denschlag, Dominik, Dürr, Hans Roland, Frese, Steffen, Gösling, Thomas, Graeter, Thomas, Grünwald, Viktor, Grützmann, Robert, Hoffmann, Jürgen, Juhasz-Boess, Ingolf, Kasper, Bernd, Kogosov, Vlada, Knoefel, Wolfram Trudo, Lehner, Burkhard, Lehnhardt, Marcus, Lindner, Lars H., Matthies, Cordula, Sehouli, Jalid, Ugurel, Selma, and Hohenberger, Peter

Published
2023
Full Text
View/download PDF

11. Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ductal adenocarcinoma: The HEAT randomised clinical trial

Author

Issels, Rolf D., Boeck, Stefan, Pelzer, Uwe, Mansmann, Ulrich, Ghadjar, Pirus, Lindner, Lars H., Albertsmeier, Markus, Angele, Martin K., Schmidt, Michael, Xu, Yujun, Bahra, Marcus, Pratschke, Johann, Schoenberg, Michael, Thasler, Wolfgang E., Salat, Christoph, Stoetzer, Oliver J., Knoefel, Wolfram T., Graf, Dirk, Wessalowski, Rüdiger, Keitel-Anselmino, Verena, Koenigsrainer, Alfred, Bitzer, Michael, Zips, Daniel, Bamberg, Michael, Fietkau, Rainer, Ott, Oliver, Kawecki, Maciej, Wyrwicz, Lucjan, Rutkowski, Piotr, Rentsch, Markus, Ababei, Juliana, Reichardt, Peter, Rigamonti, Marco, Weber, Bernhard, Abdel-Rahman, Sultan, Tschoep–Lechner, Katharina, Jauch, Karl-Walter, Bruns, Christiane J., Oettle, Helmut, von Bergwelt-Baildon, Michael, Heinemann, Volker, and Werner, Jens

Published
2023
Full Text
View/download PDF

12. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022

Author

Andreou, Dimosthenis, Barth, Thomas, Bauer, Sebastian, Blay, Jean-Yves, Blum, Veronika, Bode, Beata, Bonvalot, Sylvie, Bovee, Judith, Braam, Petra, Brodowicz, Thomas, Broto, Jean Martin, Dei Tos, Angelo, Denschlag, Dominik, Desar, Ingrid, Digklia, Antonia, Dileo, Palma, Dirksen, Uta, Douchy, Thomas, Duffaud, Florence, Eriksson, Mikael, Fröhling, Stefan, Gelderblom, Hans, Gronchi, Alessandro, Haas, Rick, Hardes, Jenrik, Hartmann, Wolfgang, Hofer, Silvia, Hohenberger, Peter, Hompes, Daphne, Huang, Paul, Italiano, Antoine, Jakob, Jens, Jones, Robin, Judson, Ian, Köhler, Günter, Kollàr, Attila, Krasniqi, Fatime, Krol, Stijn, Kunz, Wolfgang, Le Grange, Franel, Le Pechoux, Cécile, LeCesne, Alexandre, Leithner, Andreas, Liegl-Atzwanger, Bernadette, Lindner, Lars, Mechtersheimer, Gunhild, Messiou, Christina, Miah, Aisha, Pink, Daniel, Reichardt, Peter, Romagosa, Cleo, Rothermundt, Christian, Rutkowski, Piotr, Safwat, Akmel, Sangalli, Claudia, Szkandera, Joanna, Thway, Khin, Tunn, Per-Ulf, Van der Graaf, Winette, Van Houdt, Winan, Wardelmann, Eva, Zachariah, Ralph, Botter, Sander, Cerny, Thomas, Desar, Ingrid M.E., Jones, Robin L., Kunz, Wolfgang G., Liegl-Atzwanger, Berndadette, Lindner, Lars H., Miah, Aisha B., van der Graaf, Winette T.A., and van Houdt, Winan J.

Published
2023
Full Text
View/download PDF

18. Regional hyperthermia for soft tissue sarcoma – a survey on current practice, controversies and consensus among 12 European centers

Author

Roohani, Siyer, primary, Ehret, Felix, additional, Beck, Marcus, additional, Veltsista, Danai P., additional, Nadobny, Jacek, additional, Zschaeck, Sebastian, additional, Abdel-Rahman, Sultan, additional, Eckert, Franziska, additional, Flörcken, Anne, additional, Issels, Rolf D., additional, Klöck, Stephan, additional, Krempien, Robert, additional, Lindner, Lars H., additional, Notter, Markus, additional, Ott, Oliver J., additional, Pink, Daniel, additional, Potkrajcic, Vlatko, additional, Reichardt, Peter, additional, Riesterer, Oliver, additional, Spałek, Mateusz Jacek, additional, Stutz, Emanuel, additional, Wessalowski, Rüdiger, additional, Zilli, Thomas, additional, Zips, Daniel, additional, Ghadjar, Pirus, additional, and Kaul, David, additional

Published
2024
Full Text
View/download PDF

19. Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial

Author

Issels, Rolf D., Noessner, Elfriede, Lindner, Lars H., Schmidt, Michael, Albertsmeier, Markus, Blay, Jean-Yves, Stutz, Emanuel, Xu, Yujun, Buecklein, Veit, Altendorf-Hofmann, Annelore, Abdel-Rahman, Sultan, Mansmann, Ulrich, von Bergwelt-Baildon, Michael, and Knoesel, Thomas

Published
2021
Full Text
View/download PDF

29. Differentiation of benign and metastatic lymph nodes in soft tissue sarcoma

Author

Burkhard-Meier, Anton, primary, Jurinovic, Vindi, additional, Berclaz, Luc M., additional, Albertsmeier, Markus, additional, Dürr, Hans Roland, additional, Klein, Alexander, additional, Knösel, Thomas, additional, Gioia, Dorit Di, additional, Unterrainer, Lena M., additional, Schmidt-Hegemann, Nina-Sophie, additional, Ricke, Jens, additional, Bergwelt-Baildon, Michael, additional, Kunz, Wolfgang G., additional, and Lindner, Lars H., additional

Published
2023
Full Text
View/download PDF

30. Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial

Author

Schöffski, Patrick, Sufliarsky, Jozef, Gelderblom, Hans, Blay, Jean-Yves, Strauss, Sandra J, Stacchiotti, Silvia, Rutkowski, Piotr, Lindner, Lars H, Leahy, Michael G, Italiano, Antoine, Isambert, Nicolas, Debiec-Rychter, Maria, Sciot, Raf, Van Cann, Thomas, Marréaud, Sandrine, Nzokirantevye, Axelle, Collette, Sandra, and Wozniak, Agnieszka

Published
2018
Full Text
View/download PDF

32. Supplementary Figure S2 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

Author

Joensuu, Heikki, primary, Wardelmann, Eva, primary, Eriksson, Mikael, primary, Reichardt, Annette, primary, Hall, Kirsten Sundby, primary, Schütte, Jochen, primary, Cameron, Silke, primary, Hohenberger, Peter, primary, Sihto, Harri, primary, Jost, Philipp J., primary, Lindner, Lars H., primary, Bauer, Sebastian, primary, Nilsson, Bengt, primary, Kallio, Raija, primary, Pesonen, Tommi, primary, and Reichardt, Peter, primary

Published
2023
Full Text
View/download PDF

33. Study Protocol from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

Author

Joensuu, Heikki, primary, Wardelmann, Eva, primary, Eriksson, Mikael, primary, Reichardt, Annette, primary, Hall, Kirsten Sundby, primary, Schütte, Jochen, primary, Cameron, Silke, primary, Hohenberger, Peter, primary, Sihto, Harri, primary, Jost, Philipp J., primary, Lindner, Lars H., primary, Bauer, Sebastian, primary, Nilsson, Bengt, primary, Kallio, Raija, primary, Pesonen, Tommi, primary, and Reichardt, Peter, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Table S1 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

Author

Joensuu, Heikki, primary, Wardelmann, Eva, primary, Eriksson, Mikael, primary, Reichardt, Annette, primary, Hall, Kirsten Sundby, primary, Schütte, Jochen, primary, Cameron, Silke, primary, Hohenberger, Peter, primary, Sihto, Harri, primary, Jost, Philipp J., primary, Lindner, Lars H., primary, Bauer, Sebastian, primary, Nilsson, Bengt, primary, Kallio, Raija, primary, Pesonen, Tommi, primary, and Reichardt, Peter, primary

Published
2023
Full Text
View/download PDF

35. Data from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

Author

Joensuu, Heikki, primary, Wardelmann, Eva, primary, Eriksson, Mikael, primary, Reichardt, Annette, primary, Hall, Kirsten Sundby, primary, Schütte, Jochen, primary, Cameron, Silke, primary, Hohenberger, Peter, primary, Sihto, Harri, primary, Jost, Philipp J., primary, Lindner, Lars H., primary, Bauer, Sebastian, primary, Nilsson, Bengt, primary, Kallio, Raija, primary, Pesonen, Tommi, primary, and Reichardt, Peter, primary

Published
2023
Full Text
View/download PDF

36. Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review

Author

Veltsista, Paraskevi Danai, primary, Oberacker, Eva, additional, Ademaj, Adela, additional, Corradini, Stefanie, additional, Eckert, Franziska, additional, Flörcken, Anne, additional, Kaul, David, additional, Lindner, Lars H., additional, Issels, Rolf, additional, Ott, Oliver J., additional, Pink, Daniel, additional, Potkrajcic, Vlatko, additional, Reichardt, Peter, additional, Roohani, Siyer, additional, Spalek, Mateusz Jacek, additional, Riesterer, Oliver, additional, Zips, Daniel, additional, and Ghadjar, Pirus, additional

Published
2023
Full Text
View/download PDF

37. Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

Author

Schöffski, Patrick, Wozniak, Agnieszka, Escudier, Bernard, Rutkowski, Piotr, Anthoney, Alan, Bauer, Sebastian, Sufliarsky, Jozef, van Herpen, Carla, Lindner, Lars H., Grünwald, Viktor, Zakotnik, Branko, Lerut, Evelyne, Debiec-Rychter, Maria, Marréaud, Sandrine, Lia, Michela, Raveloarivahy, Tiana, Collette, Sandra, and Albiges, Laurence

Published
2017
Full Text
View/download PDF

39. TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS)

Author

Berclaz, Luc M., primary, Altendorf-Hofmann, Annelore, additional, Lindner, Lars H., additional, Burkhard-Meier, Anton, additional, Di Gioia, Dorit, additional, Dürr, Hans Roland, additional, Klein, Alexander, additional, Albertsmeier, Markus, additional, Schmidt-Hegemann, Nina-Sophie, additional, Klauschen, Frederick, additional, and Knösel, Thomas, additional

Published
2023
Full Text
View/download PDF

40. KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

Author

Joensuu, Heikki, primary, Wardelmann, Eva, additional, Eriksson, Mikael, additional, Reichardt, Annette, additional, Hall, Kirsten Sundby, additional, Schütte, Jochen, additional, Cameron, Silke, additional, Hohenberger, Peter, additional, Sihto, Harri, additional, Jost, Philipp J., additional, Lindner, Lars H., additional, Bauer, Sebastian, additional, Nilsson, Bengt, additional, Kallio, Raija, additional, Pesonen, Tommi, additional, and Reichardt, Peter, additional

Published
2023
Full Text
View/download PDF

43. Systemische Therapie von Osteosarkomen

Author

Bielack, Stefan S., Reichardt, Peter, Lindner, Lars H., and Hecker-Nolting, Stefanie

Abstract

Hintergrund: Osteosarkome sind die häufigsten primär malignen Knochentumorerkrankungen. Ihre gut etablierte Standardtherapie besteht aus einer kompletten Tumoroperation, die in eine intensive prä- und postoperative Chemotherapie eingebettet wird. Ziel: Es erfolgt die Beschreibung des Ist-Standards und aktueller Entwicklungen und Perspektiven der medikamentösen Tumortherapie in Abhängigkeit vom Patientenalter. Material und Methoden: Dabei handelt es sich um einen nichtsystematischen Literaturreview. Ergebnisse: Der Epidemiologie folgend, wurden fast alle Therapiestudien bei Kindern, Jugendlichen und jungen Erwachsenen durchgeführt. In den letzten Jahrzehnten ist in diesen allerdings eine Stagnation der Heilungsraten zu beobachten. Die Kombination der Chemotherapie mit einem Tyrosinkinasehemmer gilt als eine Möglichkeit, die diese Stagnation durchbrechen könnte. Noch stehen entsprechende Studien allerdings aus. Betroffene Erwachsene mittleren Alters profitieren ebenfalls von einer zusätzlich zur Lokaltherapie eingesetzten (neo)adjuvanten Chemotherapie. Die Auswahl der Medikamente und Dosierungen muss dabei an das Alter angepasst werden. Kaum etwas ist über noch ältere Patienten im Rentenalter bekannt, die konventionelle Chemotherapie i. d. R. schlecht tolerieren. Hier müssen, mangels aussagekräftiger Studien, individuelle Therapieangebote gefunden werden. Schlussfolgerung: Es ist zu hoffen, dass die raschen Erkenntnisgewinne zur Tumorbiologie auch bei Osteosarkompatienten jeden Alters zu relevanten therapeutischen Fortschritten führen werden.

Published
2024
Full Text
View/download PDF

44. Retroperitoneale Weichgewebssarkome: Stellenwert der Radiotherapie

Author

Nieto, Alexander, Albertsmeier, Markus, Werner, Jens, Di Gioia, Dorit, Lindner, Lars H., Rauch, Josefine, Nachbichler, Silke, Belka, Claus, and Schmidt-Hegemann, Nina-Sophie

Abstract

Hintergrund: Retroperitoneale Weichgewebssarkome (RPS) umfassen Tumoren mesenchymalen Ursprungs mit teils gut charakterisierten, histologischen Subtypen und heterogener Prognose. Die STRASS-Studie, welche den Stellenwert einer neoadjuvanten Radiotherapie beim primären RPS untersuchte, lieferte zum ersten Mal Daten in einer Phase-III-Studie. Ziel der Arbeit: Das primäre Ziel der vorliegenden Arbeit ist es, den Stellenwert der neoadjuvanten Strahlentherapie beim RPS nach Veröffentlichung der STRASS-Studie aufzuzeigen. Material und Methode: Wir führten eine nichtsystematische Literatursuche durch, die Ergebnisse retrospektiver Arbeiten wurden in Bezug zu der kürzlich erschienenen STRASS-Studie gesetzt. Ergebnisse: In den zwei größten, die amerikanischen Datenbanken National Cancer Database (NCDB) und Surveillance, Epidemiology, and End Results Program (SEER) umfassenden Analysen konnte eine Verbesserung des Gesamtüberlebens durch die Radiotherapie beim RPS gezeigt werden. Entgegen diesen Ergebnissen fiel die STRASS-Studie für den kombinierten Endpunkt des abdominal-rezidivfreien 3‑Jahres-Überlebens negativ aus. Hier konnten lediglich initial ungeplante Subgruppenanalysen einen Trend für einen Vorteil für Liposarkome sowie niedriggradige Sarkome zeigen, welcher nicht für Leiomyo- und hochgradige Sarkome nachgewiesen werden konnte. Schlussfolgerungen: Auch bei so seltenen Tumoren wie den RPS ist eine randomisierte Studie wie die STRASS-Studie dank internationaler Kooperation möglich. Die Ergebnisse der STRASS-Studie haben den Stellenwert der neoadjuvanten Radiotherapie in der Gesamtheit der Behandlung von RPS relativiert. Ein längeres Follow-up ist insbesondere zur weiteren Beurteilung des Stellenwertes der Radiotherapie bei den Liposarkomen wünschenswert.

Published
2024
Full Text
View/download PDF

45. Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience.

Author

Berclaz, Luc M., Burkhard-Meier, Anton, Lange, Philipp, Di Gioia, Dorit, Schmidt, Michael, Knösel, Thomas, Klauschen, Frederick, von Bergwelt-Baildon, Michael, Heinemann, Volker, Greif, Philipp A., Westphalen, C. Benedikt, Heinrich, Kathrin, and Lindner, Lars H.

Subjects
CANCER patients, SARCOMA, NUCLEOTIDE sequencing, MEDICAL records, PROGRESSION-free survival
Abstract

Purpose: Due to poor outcomes and limited treatment options, patients with advanced bone and soft tissue sarcomas (BS/STS) may undergo comprehensive molecular profiling of tumor samples to identify possible therapeutic targets. The aim of this study was to determine the impact of routine molecular profiling in the setting of a dedicated precision oncology program in patients with BS/STS in a German large-volume sarcoma center. Methods: 92 BS/STS patients who received comprehensive genomic profiling (CGP) and were subsequently discussed in our molecular tumor board (MTB) between 2016 and 2022 were included. Patient records were retrospectively reviewed, and the clinical impact of NGS-related findings was analyzed. Results: 89.1% of patients had received at least one treatment line before NGS testing. At least one molecular alteration was found in 71 patients (82.6%). The most common alterations were mutations in TP53 (23.3% of patients), followed by PIK3CA and MDM2 mutations (9.3% each). Druggable alterations were identified, and treatment recommended in 32 patients (37.2%). Of those patients with actionable alterations, ten patients (31.2%) received personalized treatment and six patients did benefit from molecular-based therapy in terms of a progression-free survival ratio (PFSr) > 1.3. Conclusion: Our single-center experience shows an increasing uptake of next-generation sequencing (NGS) and highlights current challenges of implementing precision oncology in the management of patients with BS/STS. A relevant number of patients were diagnosed with clinically actionable alterations. Our results highlight the potential benefit of NGS in patients with rare cancers and currently limited therapeutic options. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

46. Supplementary Video 2 from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors

Author

Manzoor, Ashley A., primary, Lindner, Lars H., primary, Landon, Chelsea D., primary, Park, Ji-Young, primary, Simnick, Andrew J., primary, Dreher, Matthew R., primary, Das, Shiva, primary, Hanna, Gabi, primary, Park, Won, primary, Chilkoti, Ashutosh, primary, Koning, Gerben A., primary, ten Hagen, Timo L.M., primary, Needham, David, primary, and Dewhirst, Mark W., primary

Published
2023
Full Text
View/download PDF

47. Data from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors

Author

Manzoor, Ashley A., primary, Lindner, Lars H., primary, Landon, Chelsea D., primary, Park, Ji-Young, primary, Simnick, Andrew J., primary, Dreher, Matthew R., primary, Das, Shiva, primary, Hanna, Gabi, primary, Park, Won, primary, Chilkoti, Ashutosh, primary, Koning, Gerben A., primary, ten Hagen, Timo L.M., primary, Needham, David, primary, and Dewhirst, Mark W., primary

Published
2023
Full Text
View/download PDF

48. Supplementary Video 1 from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors

Author

Manzoor, Ashley A., primary, Lindner, Lars H., primary, Landon, Chelsea D., primary, Park, Ji-Young, primary, Simnick, Andrew J., primary, Dreher, Matthew R., primary, Das, Shiva, primary, Hanna, Gabi, primary, Park, Won, primary, Chilkoti, Ashutosh, primary, Koning, Gerben A., primary, ten Hagen, Timo L.M., primary, Needham, David, primary, and Dewhirst, Mark W., primary

Published
2023
Full Text
View/download PDF

49. Supplementary Materials and Methods from Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors

Author

Manzoor, Ashley A., primary, Lindner, Lars H., primary, Landon, Chelsea D., primary, Park, Ji-Young, primary, Simnick, Andrew J., primary, Dreher, Matthew R., primary, Das, Shiva, primary, Hanna, Gabi, primary, Park, Won, primary, Chilkoti, Ashutosh, primary, Koning, Gerben A., primary, ten Hagen, Timo L.M., primary, Needham, David, primary, and Dewhirst, Mark W., primary

Published
2023
Full Text
View/download PDF

50. Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022

Author

Rothermundt, Christian, primary, Andreou, Dimosthenis, additional, Blay, Jean-Yves, additional, Brodowicz, Thomas, additional, Desar, Ingrid M.E., additional, Dileo, Palma, additional, Gelderblom, Hans, additional, Haas, Rick, additional, Jakob, Jens, additional, Jones, Robin L., additional, Judson, Ian, additional, Kunz, Wolfgang G., additional, Liegl-Atzwanger, Berndadette, additional, Lindner, Lars H., additional, Messiou, Christina, additional, Miah, Aisha B., additional, Reichardt, Peter, additional, Szkandera, Joanna, additional, van der Graaf, Winette T.A., additional, van Houdt, Winan J., additional, Wardelmann, Eva, additional, Hofer, Silvia, additional, Barth, Thomas, additional, Bauer, Sebastian, additional, Blum, Veronika, additional, Bode, Beata, additional, Bonvalot, Sylvie, additional, Bovee, Judith, additional, Braam, Petra, additional, Broto, Jean Martin, additional, Dei Tos, Angelo, additional, Denschlag, Dominik, additional, Desar, Ingrid, additional, Digklia, Antonia, additional, Dirksen, Uta, additional, Douchy, Thomas, additional, Duffaud, Florence, additional, Eriksson, Mikael, additional, Fröhling, Stefan, additional, Gronchi, Alessandro, additional, Hardes, Jenrik, additional, Hartmann, Wolfgang, additional, Hohenberger, Peter, additional, Hompes, Daphne, additional, Huang, Paul, additional, Italiano, Antoine, additional, Jones, Robin, additional, Köhler, Günter, additional, Kollàr, Attila, additional, Krasniqi, Fatime, additional, Krol, Stijn, additional, Kunz, Wolfgang, additional, Le Grange, Franel, additional, Le Pechoux, Cécile, additional, LeCesne, Alexandre, additional, Leithner, Andreas, additional, Liegl-Atzwanger, Bernadette, additional, Lindner, Lars, additional, Mechtersheimer, Gunhild, additional, Miah, Aisha, additional, Pink, Daniel, additional, Romagosa, Cleo, additional, Rothermundt, Christian, additional, Rutkowski, Piotr, additional, Safwat, Akmel, additional, Sangalli, Claudia, additional, Thway, Khin, additional, Tunn, Per-Ulf, additional, Van der Graaf, Winette, additional, Van Houdt, Winan, additional, Zachariah, Ralph, additional, Botter, Sander, additional, and Cerny, Thomas, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results